Aspire Impact and Aspire Circle, supported by Capgemini, unveiled India’s inaugural ESG performance framework tailored to healthcare and pharma in New Delhi. Featuring 80 general ESG indicators plus 27 sector-specific ones, it enables better evaluation of risks (e.g., biomedical waste, antimicrobial resistance) and opportunities (e.g., green hospitals, digital health). Major names like Fortis, Apollo, Quadria, and Tata Capital took part. The initiative aims to drive sustainable practices in India’s $310 billion health & pharma sector.
India launches first ESG framework for healthcare & pharma
